Trace the evolution of haemoglobin research and examine its relevance to India's contemporary blood-disorder elimination strategies.

Haemoglobin, the iron-bearing respiratory protein that carries oxygen from the lungs to tissues, has moved from being an object of laboratory curiosity to the operational basis of a national health mission. Tracing this arc shows how basic protein science underwrites India's screening-led strategy against sickle-cell disease (SCD).

Evolution of haemoglobin research

• Molecular decoding: SCD was traced to a mutation in the HBB gene, yielding abnormal haemoglobin S and rigid, sickle-shaped red cells that obstruct blood flow [1].
• Disassembly and reassembly: in 1976, Dr. Sherman Beychok of Columbia University told the American Chemical Society that a haemoglobin molecule could be taken apart and rebuilt, binding synthetic globin chains to heme without disintegration — removing the chief barrier to man-made haemoglobin [2].
• Comparative pathology: the stated purpose was to compare synthetic healthy haemoglobin with synthetic sickle-cell haemoglobin, making the molecule itself a diagnostic reference point [2].
• Acknowledged limits: Beychok cautioned that artificial haemoglobin could not substitute for whole-blood transfusion in trauma care — a caveat that still shapes blood-policy realism [2].

Relevance to India's elimination strategy

• Diagnostics: knowledge of variant haemoglobin enables Point-of-Care Testing kits used for mass screening under the National Sickle Cell Anaemia Elimination Mission (NSCAEM), launched on 1 July 2023 at Shahdol [3].
• Scale and equity: NSCAEM targets 7 crore people aged 0–40 in tribal-dominated districts; over 6 crore screenings, 2.15 lakh diagnoses and 16.7 lakh carriers have been recorded [4].
• Prevention over cure: carrier identification permits counselling and genetic advice — the core preventive logic for the 2047 elimination goal [4].
• Global convergence: WHO urges integrating SCD care into primary health systems, mirroring NSCAEM's Ayushman Bharat-linked delivery [1].

Thus, laboratory work on a single protein has matured into population-scale public health action. Going forward, coupling screening with counselling safeguards, curative research and strengthened transfusion services would convert detection into treatment — advancing SDG-3 and the constitutional promise of health equity under Article 21.